Coppertone

Quick links to important sections

Coppertone

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Coppertone

Property Description
Primary Class Over-the-Counter (OTC) Drug
Active Ingredients Various UV filters (e.g., Avobenzone, Zinc Oxide)
Form Lotion, spray, stick, gel, etc.
Common Use Protection against UV radiation (sunscreen)
Origin Formulated in the mid-1940s by Benjamin Green

Coppertone is a prominent brand of sunscreen and sun care products, originally developed in the mid-1940s. In the United States, it is formally classified as an Over-the-Counter (OTC) Drug Product. This designation subjects the product to rigorous regulatory oversight to ensure its safety and effectiveness when utilized for sun protection.

Brand Differentiation and Function

The Coppertone brand is distinguished by its wide array of formulations tailored for specific users, including products for infants, formulas designed for sports activities, and mineral-only sunscreens. The brand's products utilize active ingredients—UV filters—to protect the skin from harmful ultraviolet (UV) radiation. These filters are regulated as drugs because their purpose is to prevent specific conditions, such as sunburn and the long-term effects of sun exposure.

This protective function is generally recognized for its role in reducing the risk of skin cancer and photoaging, a conclusion supported by extensive clinical evidence. The formulations use both chemical (organic) filters, which absorb UV light, and physical (inorganic) filters, like Zinc Oxide and Titanium Dioxide, which primarily reflect and scatter UV radiation away from the skin. This blended approach helps deliver the necessary broad-spectrum protection against both UVA and UVB rays.

What side effects are possible with Coppertone?

Possible Side Effects and Safety Information

The official safety profile for topical sunscreens, which are regulated as Over-the-Counter (OTC) Drug Products like Coppertone, primarily outlines potential localized adverse reactions. These reactions are typically classified under Skin and Subcutaneous Tissue Disorders by regulatory authorities such as the FDA.


Documented Adverse Reactions

The majority of documented adverse events are local and non-systemic, including potential occurrences of rash, itching, skin irritation, stinging, burning, and redness at the site of application. While regulatory labeling does not typically assign numerical frequencies (e.g., 'common' or 'rare'), these effects are listed as known potential outcomes.

Serious adverse reactions are defined in regulatory documents as those that persist, worsen, or involve severe manifestations, such as a rash with weeping blisters, which may indicate a severe allergic or hypersensitivity response warranting cessation of use.


High-Level Safety Considerations

Safety information also includes specific population constraints and application restrictions. Official labeling mandates that the product should not be used on infants under 6 months without consulting a health professional. Furthermore, the product is restricted from use on damaged or broken skin and should be kept out of the eyes.

A key regulatory focus is on systemic absorption: the FDA has noted that multiple active UV filter ingredients are measurably absorbed into the bloodstream. This finding necessitates ongoing regulatory assessment of the safety of chronic, long-term exposure. Aerosol or spray formulations also carry warnings regarding the risks of accidental inhalation.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose scenarios for sunscreens, such as Coppertone, are formally documented in regulatory guidance based on the route of exposure. The official profile primarily distinguishes between localized reactions and the critical risk associated with accidental ingestion.

Documented Overdose Manifestations

Excessive topical application may result in severe dermal irritation or redness. Accidental exposure to mucosal areas, such as the eyes, can cause localized irritation. The most severe presentations follow accidental ingestion of significant quantities, which may lead to acute systemic toxicity related to non-active product components in the vehicle, rather than the UV filters themselves.

Emergency Actions Required

Regulatory labeling mandates specific actions in case of overdose or exposure. Immediate medical attention must be sought following the accidental swallowing of the product, as this constitutes the primary life-threatening risk. Furthermore, individuals must contact a Poison Control Center immediately upon suspected ingestion to initiate management procedures.

Official Management and Monitoring

Management is strictly defined as symptomatic and supportive treatment. No specific antidote for the active UV filters is formally known or documented in the official regulatory information. For significant accidental ingestion, hospital monitoring may be required to observe for potential signs of systemic toxicity, particularly given the elevated pediatric ingestion risk acknowledged in regulatory summaries.

Therapeutic Uses of Coppertone

What Coppertone Treats: Main Uses and Benefits

Coppertone products are applied across therapeutic domains involving chronic and acute UV exposure, generally to manage risk. The core purpose is to manage the documented, harmful effects of ultraviolet radiation.

Quick Fact: Managing Photo-Damage Risk

Coppertone is commonly used to help with symptoms related to physical discomfort and is relevant in situations where symptoms may intensify temporarily due to cumulative damage. This may assist with managing symptom clusters related to acute sunburn (redness and tenderness) and plays a role in managing the risk of developing skin cancer and the signs of premature skin aging.

“The product is commonly used to help with symptoms that interfere with daily functioning, providing supportive relief.”

Key Therapeutic Benefits

This protective function contributes to improved day-to-day comfort by managing the risks of chronic conditions and acute inflammatory episodes. It supports general well-being and is relevant when supportive symptom management is appropriate for preserving skin integrity.

Eligibility and Restrictions for Use

Eligibility Scope

Classification Population or Condition
Use Allowed (Standard) General Population and Children aged 6 months and older.
Use Contraindicated Individuals with damaged or broken skin; Individuals with known allergy to product components.
Use Restricted/Conditional Infants under 6 months of age (requires medical consultation).
Maternal Health Status Pregnant or breastfeeding individuals (conditional use; must ask a health professional).

Official Eligibility Statements

Regulatory documents define eligibility through a few specific constraints. The product must not be used on damaged or broken skin. For children under 6 months of age, the label mandates a consultation to ask a doctor. Similarly, individuals who are pregnant or breastfeeding must ask a health professional before use. The label also requires users to stop use and ask a doctor immediately if a rash or irritation occurs, revoking eligibility for continued use. Coppertone is restricted to external application only.

Connection to the Overall Eligibility Profile

Official regulatory documents from the FDA OTC Sunscreen Monograph define eligibility primarily through age-based restrictions and local skin integrity constraints. Use is generally permitted for the public aged six months and older. Eligibility is conditional or prohibited only in specific circumstances where regulatory bodies require mandatory medical consultation or absolute exclusion.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Coppertone, an Over-the-Counter (OTC) topical drug product, is defined by substance and environmental constraints rather than interactions with systemic medications.


Interaction Scope and Restrictions

The regulatory labeling, consistent with the product's external application, does not document pharmacokinetic (CYP enzyme or transporter-mediated) or pharmacodynamic interactions with co-administered prescription or non-prescription systemic drugs. The interaction profile is thus notable for the absence of systemic drug interaction data.

A key mandatory interaction rule is related to the product’s formulation vehicle. Flammable spray formulations contain specific warnings prohibiting co-exposure with heat, flame, or smoking due to the presence of high concentrations of Alcohol. This represents a non-systemic, substance-based restriction that requires spatial and timing separation during use.


Regulatory Prohibitions

Interaction-related restrictions also include prohibitions based on manufacturing safety. Official regulatory alerts have mandated the prohibition of use and disposal of specific product lots contaminated with the unapproved non-active substance, Benzene. This action constitutes a regulatory constraint on product use due to unacceptable substance exposure risk, classifying the affected products as strictly prohibited for administration.

The overall interaction structure is defined by safety constraints (flammability) and quality controls (contamination), rather than complex drug-drug interaction mechanisms.

Mechanism of Action

How Coppertone Works: Mechanism of Action

️ Photon Interception and Physical Filtration

The mechanism of active ingredients in Coppertone products is defined by photoprotection—a physical-chemical intervention that targets Ultraviolet Radiation (UVR) photons before they reach viable skin cells. Organic filters, such as Avobenzone, utilize their chemical structure to absorb high-energy UV photons. The absorbed energy is then dissipated as low-level heat as the electrons return to their ground state. Inorganic filters, like Zinc Oxide, work primarily through the physical mechanisms of reflection and scattering of UV radiation.

Prevention of Molecular and Inflammatory Cascades

By intercepting UV photons, the mechanism prevents primary photo-damage, such as the formation of DNA lesions in keratinocytes. This interruption halts the release of danger signals, suppressing the local production of pro-inflammatory mediators like prostaglandins. This ensures that the physiological processes leading to UV-induced vasodilation and increased permeability are not initiated, contributing to the preservation of local tissue integrity.

️ Synergy for Broad-Spectrum Efficacy

The overall mechanism relies on the complementary actions of multiple filters to intercept photons across the UV spectrum. Zinc Oxide provides broad scattering and absorption across both UVA and UVB rays, while organic filters enhance specific UVA I absorption. This synergistic approach contributes to minimizing the total UV dose impacting the skin, which is relevant to the processes that limit both the acute inflammatory response and the chronic generation of Reactive Oxygen Species (ROS).

Dosage and Administration Information

Official Administration Guidelines for Sunscreen Drug Products

Coppertone products are classified as Over-the-Counter (OTC) Sunscreen Drug Products, and their usage is strictly defined by regulatory requirements for topical administration. These official instructions specify the required quantity, timing, and conditions of reapplication necessary to achieve the labeled Sun Protection Factor (SPF).


Administration Scope

Category Instruction Entity (Strictly Label-Based)
Route of administration Topical (external application only).
Dosing schedule Applied liberally to all exposed skin areas 15 minutes before sun exposure, as specified in regulatory labeling.
Preparation requirements Certain liquid forms may require shaking well before use to ensure proper suspension of ingredients.
Age-group administration rules For children under 6 months of age, the label mandates consultation with a doctor before administration.
Special procedural conditions Reapplication is mandatory immediately after towel drying and after 40 or 80 minutes of swimming or sweating, depending on the product’s water resistance rating.

Instruction Classifications (High-Level)

Category Classification Entity
Administration method type Topical (non-systemic application).
Frequency pattern As-needed (situational), with reapplication required at least every two hours.
Regulatory basis OTC Monograph.
Use-context constraints Use is contingent upon the anticipation of sun exposure and factors that may remove the product (water, sweat).

Resulting Procedural Structure

Official step sequence:

  • Apply the product liberally to exposed skin 15 minutes before sun exposure.
  • Reapply at least every 2 hours during continued sun exposure.
  • Reapply after swimming or sweating for the labeled duration (40 or 80 minutes).
  • Reapply immediately after towel drying.

Connection to the overall use protocol (2–4 sentences): The official instructions establish a precise time-dependent protocol that dictates when and how much product must be administered to achieve the labeled photoprotection. These directions define a pattern of use that is situational and recurrent, linking dosage frequency directly to environmental factors and the anticipated duration of ultraviolet (UV) exposure.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Coppertone

Evidence for Use in Reducing Skin Cancer Risk

Research has examined the role of sun protection in studies exploring outcomes related to long-term skin conditions, including various forms of skin cancer. Randomized Controlled Trials (RCTs) were studied for their potential to provide insights into outcomes related to specific cancer types, such as Squamous Cell Carcinoma and precancerous lesions. Studies explored the incidence rates of Melanoma and Non-Melanoma skin cancers over extended time intervals, with follow-up for some controlled trials lasting up to 21 years. However, variability and inconsistency were noted across the full body of evidence, especially in observational studies examining the association with Melanoma risk. Findings indicate that real-world application thickness is often lower than the required testing dose, meaning results apply only to the populations studied under trial conditions.


Evidence for Prevention of Acute Sunburn (Erythema)

Research explored the outcomes of product application against short-term, acute sun damage, such as sunburn (erythema), in controlled settings. In Vivo RCTs were used to measure the Minimal Erythema Dose (MED) on protected and unprotected skin, and studies monitored the maintenance of the Sun Protection Factor (SPF) value after standardized water immersion. Controlled testing described patterns where protected skin requires a higher UV dose to produce erythema compared to unprotected skin. Evidence is limited regarding the true protection level when products are applied suboptimally or non-uniformly, as observed application patterns differ significantly from testing standards.


Evidence for Preventing Signs of Photoaging

Research has explored the evaluation of risk associated with premature skin aging (photoaging). Randomized Controlled Trials compared subjects who applied sunscreen daily versus those who used it discretionarily. Studies monitored outcomes related to systemic or functional imbalance, including the progression of microtopography grades and changes in dermal components. Controlled trials reported observations of differences in the rate of change of skin aging markers between the daily-use and discretionary-use groups over several years. Outcomes measured primarily reflect protection against UV light.


Long-Term Research and Uncertainties

Studies observing responses over defined time intervals have been crucial for assessing long-term outcomes, with follow-up durations being limited to the span of the original cohorts. Evidence for sunscreen use was studied for various populations, including children and patients with photosensitive skin conditions; however, subgroup findings are uncertain for specific ethnic groups. Key research gaps remain concerning the discrepancy between laboratory testing and real-world application, the need for more data on long-term effects of certain UV filter components, and the role of visible light and infrared spectrums in damage, where research is limited.

Key Studies & References

  1. FDA Monographs and Current Regulations for Sunscreen Products
  2. Sunscreens and Photoprotection - StatPearls - NCBI Bookshelf

Frequently Asked Questions (FAQ)

Common questions about Coppertone (FAQ)


Q: Is Coppertone the same as regular sunscreen, or is it different?

A: According to U.S. regulatory standards, Coppertone products are classified as Over-the-Counter (OTC) Sunscreen Drug Products. This designation means the product's primary purpose is regulated by the Food and Drug Administration (FDA) to function as a drug, providing protection to the skin from ultraviolet (UV) radiation.

Q: Can Coppertone interact with any common skin care products?

A: Official regulatory information primarily addresses potential interactions with systemic medications and does not typically document use alongside non-drug cosmetic items like moisturizers or serums. It is important to note that the interaction profile is mainly defined by the product's external, topical application.

Q: Is it possible to be allergic to an ingredient in Coppertone?

A: Official product warnings indicate that use is prohibited for individuals who have a known allergy to any of the product's components. If a user experiences symptoms such as a rash or irritation, official guidance states use should be ceased.

Q: Is Coppertone safe for children to use?

A: The regulatory eligibility profile permits its use for children aged 6 months and older. For infants under 6 months of age, regulatory instructions require that a health professional be consulted prior to use.

Q: What does the term 'broad spectrum' mean when describing Coppertone?

A: 'Broad Spectrum' is a specific regulatory classification granted to sunscreens that have demonstrated protection against both types of harmful ultraviolet radiation: UVA and UVB. This classification indicates the product meets the testing standards for protection across the UV spectrum.

Q: Can Coppertone be used by people with sensitive skin?

A: Official warnings list localized reactions like skin irritation, redness, or stinging as potential adverse events. Due to this possibility, official guidance specifies that use must be discontinued immediately if a rash or irritation develops.

Q: Does Coppertone cause breakouts or acne?

A: The official safety profile for the product documents potential localized adverse skin reactions such as irritation and rash. However, official regulatory documentation does not specifically list or classify acne or breakouts as known side effects.

Q: Does Coppertone expire, and how can I tell?

A: Sunscreen products are regulated to ensure they maintain their labeled strength for at least three years from manufacture. Official product information states that an expiration date must be printed on the label unless stability testing supports a longer shelf life. This date indicates the limit for the product's guaranteed quality and purity.

Q: What happens if I use expired Coppertone?

A: Official product information indicates that sunscreens that have passed their expiration date may no longer retain their full labeled effectiveness. For this reason, regulatory guidance specifies that expired products should be discarded to ensure the maintenance of labeled effectiveness.

Q: Can Coppertone interfere with prescription topical medications?

A: The official interaction profile primarily details the absence of documented systemic drug interactions. Regulatory documents do not typically specify information regarding the co-application of the product with other topical prescription medications.

Q: Is it necessary to apply a moisturizer before or after Coppertone?

A: The regulatory instructions mandate that the sunscreen be applied liberally to exposed skin 15 minutes prior to sun exposure. The official documentation does not provide specific instructions or restrictions regarding the sequential use or layering of non-drug cosmetic products, such as moisturizers.

Q: Is it common to have a mild skin reaction when first using Coppertone?

A: Official safety documents list potential localized reactions like irritation and mild rash as possible adverse events. The documentation, however, does not provide numerical data on how frequently these reactions occur in the general population or whether they are more common during the first few applications.

Q: Is there a maximum amount of Coppertone I can use in a day?

A: Official product labeling specifies that the product must be applied 'liberally' to exposed skin, which is the amount necessary to achieve the labeled Sun Protection Factor (SPF). Regulatory documentation does not provide an explicit warning or statement regarding a maximum amount or total daily exposure limit.

Q: Does the SPF number on Coppertone relate directly to the time of protection?

A: The Sun Protection Factor (SPF) number is a regulatory measure of protection against UVB rays, determined under controlled testing conditions. The SPF number does not directly correlate with or extend the duration of protection. Official instructions mandate that the product must be reapplied at least every two hours during continued sun exposure, regardless of the SPF value.

Q: Are there any known long-term side effects from using Coppertone regularly?

A: Findings published by the FDA indicate that multiple active UV filter ingredients are measurably absorbed into the bloodstream. This necessitates ongoing regulatory assessment and further testing to evaluate the long-term safety profile related to chronic, repeated use.

Q: What should I look for on the label of Coppertone if I have allergies?

A: Official labeling requires that all active and inactive ingredients used in the product formulation be listed alphabetically. Individuals with known allergies may refer to this mandatory ingredient list to identify any component that may cause a reaction.

Q: What is the primary difference between SPF 30 and SPF 50 Coppertone?

A: The difference is described by the percentage of UVB rays that are blocked under controlled testing. Official data indicates that SPF 30 blocks approximately 97% of UVB rays, while the higher SPF 50 blocks about 98% of UVB rays.

Q: Does Coppertone leave a white cast on darker skin tones?

A: Regulatory commentary acknowledges that sunscreens containing physical filters, such as Zinc Oxide, are associated with a cosmetic characteristic commonly known as a white cast. This effect is a documented characteristic related to the appearance of certain product formulations on the skin.

Q: Does Coppertone prevent tanning completely?

A: Official regulatory sources indicate that no sunscreen product can block 100% of ultraviolet (UV) radiation. While the product is officially designed to reduce UV exposure and risk of sunburn, it cannot completely block the rays that contribute to the process of tanning.

Q: Can I apply makeup over Coppertone?

A: The official administration protocol specifies applying the product to exposed skin 15 minutes before sun exposure. Official regulatory documentation does not provide instructions or restrictions related to the application sequence when layering non-drug cosmetic products, such as makeup.

Q: Is it common for people to report stomach issues related to Coppertone exposure?

A: The official product safety profile focuses on documented localized adverse reactions at the site of application and potential inhalation risk from certain aerosol formulations. Official regulatory labeling does not include or document systemic side effects, such as gastrointestinal or stomach issues.

Q: Is there any research on Coppertone's use in combination with bug spray?

A: Public health authorities, such as the CDC, generally advise against using combination sunscreen and insect repellent products because sunscreen requires reapplication more frequently than insect repellent. The suggested public health application order is to use sunscreen before the repellent.

Q: Why does Coppertone need to be reapplied so often?

A: Official administration guidelines mandate reapplication at least every two hours, as well as after swimming, sweating, or towel drying. This strict schedule is required because the photoprotective ingredients are known to degrade or be removed from the skin over time and through physical activity.

How should Coppertone be stored and disposed of?

Storage and Disposal Conditions for Coppertone Sunscreen

Coppertone products must be stored and disposed of according to official regulatory labeling to ensure stability and safety.


Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store between 20° to 25°C (68° to 77°F).
Protection Protect the product from excessive heat and direct sun.
Child Safety Keep out of reach of children.

Handling and Disposal

Aerosol (Spray) Formulations are classified as flammable and require specific constraints. They must not be stored above 120°F or used near heat or flame. The pressurized container must not be punctured or incinerated during disposal. Expired sunscreens should be discarded as they may lose their labeled effectiveness.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Coppertone found in:

A-Z Index: